Hamidou Niangaly

Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial

Issaka Sagara, Abdoul Habib Béavogui, Issaka Zongo et al. · The Lancet · 2018 · 133 citations · Full text

Common Epidemiology of<i>Rickettsia felis</i>Infection and Malaria, Africa

Oleg Mediannikov, Cristina Socolovschi, Sophie Edouard et al. · Emerging infectious diseases · 2013 · 115 citations · Full text

Coxiella burnetii-positive PCR in febrile patients in rural and urban Africa

Emmanouil Angelakis, Oleg Mediannikov, Cristina Socolovschi et al. · International Journal of Infectious Diseases · 2014 · 54 citations · Full text

Sulfadoxine–pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival

Aminatou Koné, Marga van de Vegte‐Bolmer, Rianne Siebelink‐Stoter et al. · International Journal for Parasitology · 2010 · 54 citations · Full text

Antiparasitic Agent, Medicine, Malaria +6

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali

Hamma Maiga, Estrella Lasry, Modibo Diarra et al. · PLoS ONE · 2016 · 41 citations · Full text